Found 30 matching trials
A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer PHASE2 The purpose of this study is to identify the highest tolerable dose of pyro...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer PHASE2 The main purpose of this study was to observe the efficacy and safety of tr...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2 N/A At present, the main characteristics of the enrolled population in the clin...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer PHASE3 This is a randomised, double-blind multicenter Phase III study for evaluati...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Study of Tislelizumab Combined With DisitamabVedotin and Pyrotinib Maleate in HER2-positive or Mutated Advanced Colorectal Cancer Who Failed Standard Therapy PHASE2 This study will explore the efficacy and safety of tislelizumab (PD1 inhibi...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors PHASE1 Part 1: to assess the safety and tolerability of pyrotinib and to define th...
Show More Location
University of California, Irvine School of Medicine
Learn More & Join Trial
Effect of Fluconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects PHASE1 The primary objective of the study is to evaluate the effect of fluconazole...
Show More Location
Jinan Central Hospital
Learn More & Join Trial
Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer PHASE1 This study was designed to evaluate the efficacy and safety of pyrotinib co...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer NA This is a randomized, double-blind multicenter Phase III study for evaluati...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP PHASE4 This study is a single-arm, single-center exploratory clinical study. Twent...
Show More Location
Multiple Locations
Learn More & Join Trial